
Nuvectis Pharma, Inc.
NVCTNasdaqCIK 1875558HealthcareFiscal year ends Dec 31
Reports and events: 72 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-2708:31 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001104659-23-036896 |
| 2023-03-0817:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-003181 |
| 2023-03-0711:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-029405 |
| 2022-11-0809:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-115724 |
| 2022-11-0808:18 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016755 |
| 2022-08-1509:09 ET | S-1 | Registration statement | 0001104659-22-090692 |
| 2022-08-1013:33 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013018 |
| 2022-08-0508:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086454 |
| 2022-07-2917:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-084332 |
| 2022-05-1216:43 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001377 |
| 2022-05-1109:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-058628 |
| 2022-03-2817:22 ET | SC 13D | Ownership report, active investor | 0001104659-22-038886 |
| 2022-03-2317:23 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001104659-22-037110 |
| 2022-03-2209:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-036359 |
| 2022-02-0410:20 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-011786 |
| 2022-01-2420:42 ET | S-1/A | Registration statement, amended | 0001104659-22-006586 |
| 2022-01-1818:40 ET | S-1/A | Registration statement, amended | 0001104659-22-004520 |
| 2021-11-3007:59 ET | S-1/A | Registration statement, amended | 0001104659-21-144715 |
| 2021-11-0814:19 ET | S-1/A | Registration statement, amended | 0001104659-21-135553 |
| 2021-10-2809:28 ET | S-1/A | Registration statement, amended | 0001104659-21-130769 |
| 2021-10-2119:59 ET | S-1/A | Registration statement, amended | 0001104659-21-128180 |
| 2021-10-0617:12 ET | S-1 | Registration statement | 0001104659-21-123697 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 08:08 ET. Listed shows no prices and gives no investment advice.